Literature DB >> 19615921

A semaphorin 3A inhibitor blocks axonal chemorepulsion and enhances axon regeneration.

Marisol Montolio1, Joaquim Messeguer, Isabel Masip, Patricia Guijarro, Rosalina Gavin, José Antonio Del Río, Angel Messeguer, Eduardo Soriano.   

Abstract

Secreted semaphorins are a large group of extracellular proteins involved in a variety of processes during development, including neuronal migration and axon guidance. We screened a peptoid combinatorial library to search for semaphorin 3A inhibitors, and identified a peptoid (SICHI: semaphorin Induced chemorepulsion inhibitor) that blocks semaphorin 3A-chemorepulsion and growth-cone collapse in axons at millimolar concentrations. SICHI inhibits the binding of semaphorin 3A to its receptor complex (neuropilin 1/plexin A1) and semaphorin 3A-induced phosphorylation of GSK3. Chemorepulsion induced by semaphorin 3F or netrin 1 is not blocked by SICHI. We also show that SICHI promotes neural regeneration of damaged axons. We suggest that SICHI, a selective inhibitor of semaphorin 3A, is of therapeutic interest for approaches aimed at promoting axonal regeneration and brain repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615921     DOI: 10.1016/j.chembiol.2009.05.006

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  25 in total

Review 1.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

2.  Regenerating cortical connections in a dish: the entorhino-hippocampal organotypic slice co-culture as tool for pharmacological screening of molecules promoting axon regeneration.

Authors:  José Antonio del Río; Eduardo Soriano
Journal:  Nat Protoc       Date:  2010-01-21       Impact factor: 13.491

3.  Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility.

Authors:  Vera Procaccia; Hironao Nakayama; Akio Shimizu; Michael Klagsbrun
Journal:  Biochem Biophys Res Commun       Date:  2014-04-20       Impact factor: 3.575

4.  Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Authors:  Pablo Villoslada; Gemma Vila; Valeria Colafrancesco; Beatriz Moreno; Begoña Fernandez-Diez; Raquel Vazquez; Inna Pertsovskaya; Irati Zubizarreta; Irene Pulido-Valdeolivas; Joaquin Messeguer; Gloria Vendrell-Navarro; Jose Maria Frade; Noelia López-Sánchez; Meritxell Teixido; Ernest Giralt; Mar Masso; Jason C Dugas; Dmitri Leonoudakis; Karen D Lariosa-Willingham; Lawrence Steinman; Angel Messeguer
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

5.  Analysis of axonal growth and cell migration in 3D hydrogel cultures of embryonic mouse CNS tissue.

Authors:  Vanessa Gil; José Antonio del Río
Journal:  Nat Protoc       Date:  2012-01-19       Impact factor: 13.491

Review 6.  Semaphorins and plexins as therapeutic targets.

Authors:  Thomas Worzfeld; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2014-08       Impact factor: 84.694

7.  Mitochondria Localize to Injured Axons to Support Regeneration.

Authors:  Sung Min Han; Huma S Baig; Marc Hammarlund
Journal:  Neuron       Date:  2016-12-21       Impact factor: 17.173

Review 8.  Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration.

Authors:  Oscar Seira; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2013-10-25       Impact factor: 5.590

Review 9.  Axon regeneration in C. elegans: Worming our way to mechanisms of axon regeneration.

Authors:  Alexandra B Byrne; Marc Hammarlund
Journal:  Exp Neurol       Date:  2016-08-26       Impact factor: 5.330

10.  Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling.

Authors:  Anton Pekcec; Kazim Yigitkanli; Joo Eun Jung; Stefanie Pallast; Changhong Xing; Alexander Antipenko; Maria Minchenko; Dimitar B Nikolov; Theodore R Holman; Eng H Lo; Klaus van Leyen
Journal:  FASEB J       Date:  2012-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.